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1. Introduction 
Intravenous lipid emulsions (ILEs) have been marketed to infuse fat within total parenteral 
nutrition (TPN) in order to prevent essential fatty acid deficiency. Only recently, ILEs have 
been recognized to have therapeutic effects in gastrointestinal, cardiovascular, pulmonary, 
oncologic, autoimmune, and critical care diseases. At the same time, toxic substances such as 
phytosterols have been found in ILEs. Phytosterols have been related to a TPN-associated 
complication defined parenteral nutrition-associated cholestasis (PNAC) (1-5).  
In a previous study (6), we found phytosterols to be considerably present in all the lipid 
emulsions analyzed so as to exceed the amount physiologically absorbed by the gut. In this 
study, we want to determine the plasma amount of phytosterols deriving from different oil 
sources in rats receiving parenteral nutrition, and compare it  with those in rats on standard 
oral diet. Subsequently, we want to verify whether phytosterols have an impact on the 
occurrence of cholestasis. Finally, we intend to verify whether the addition of glutamine 
changes the outcomes.   
Phytosterols, cholesterol, intravenous lipid emulsions, cholestasis, gas chromatography 
ILEs: intravenous lipid emulsions 
PNAC: parenteral nutrition-associated cholestasis 
IL: parenteral nutrition with soy bean oil 
TPN : total parenteral nutrition 
ILG:  parenteral nutrition with soy bean oil plus glutamine 
CTR: standard control 
ALT : alanine aminotransferase  
ALKP : alkaline phosphatase 
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GC : gas chromatography 
SD: standard deviation  
2. Materials and methods 
2.1 Animal experiments 
Animal and plant sterols were quantified in  the plasma of fifteen  7-week-old genetically 
inbred male Wistar rats (Charles River, Calco, Como, Italy), divided in three groups: one 
group  was infused with TPN containing Intralipid® (Fresenius Kabi AG, Germany) as lipid 
emulsion (IL), a second group received the same regimen with the addition of glutamine 
(15% of total amino acid composition) (ILG), and the third group was fed chow and served 
as standard control (CTR). PN was daily injected intraperitoneally for 5 days. Diets were 
isocalorical and their gross energy density was 10 kcal/die, divided into protein 20, lipid 40 
and carbohydrate 40 in case of TPN and 5% fats (from soy), 20% proteins, and the remaining 
carbohydrates from chow.  The animals, housed in individual room with controlled 
temperature and light conditions, had open access to food (Mucedola 2518; Settimo 
Milanese, Milan, Italy). They were allowed to acclimatize to these conditions for a week, 
then they were randomly divided into the three groups. Animal care, housing and killing 
met the guidelines of the Italian Health Ministry, which approved the study. Rats were 
weighted at the beginning of the study and before being killed. In the fifth day the animals 
were killed and their blood and liver samples were taken. Some blood samples were sent to 
the laboratory to determine liver function tests, lipid profile, and bile acids by enzymatic 
method, while others were collected in Eppendorf with EDTA and stored at – 80°C until 
analysis. Some liver samples (4–6 μm) were fixed in 10% neutral buffered formalin for 48 h, 
embedded in paraffin, and stained with hematoxylin and eosin prior to microscopic 
examination.   
2.2 Reagents, solvents, and standards 
Chloroform (analytical reagent grade), n-hexane (analytical reagent grade), methanol 
(Lichrosolv), diethyl ether, anhydrous sodium sulphate, potassium chloride, and potassium 
hydroxide were supplied by Merck (Darmstadt, Germany). Acetone (AnalaR) was 
purchased from BDH (VWR International Ltd., Leicestershire, UK). Bidistilled water and 
silylating agents (pyridine, hexamethyldisilazane and trimethylchlorosilane) were supplied 
by Carlo Erba (Milano, Italy).  (24R)-ethylcholest-5-en-3-ol (-sitosterol) purity: 60% -
sitosterol and 30% (24R)-methylcholest-5-en-3-ol (campesterol) was purchased from 
Research Plus (Bayonne, NJ, USA). (24S)-Ethylcholest-5,22-dien-3-ol (stigmasterol) (purity: 
93%), cholest-5-en-3-ol (cholesterol) (purity: 99%), and 5-cholestane (purity: 97%) were 
purchased from Sigma (St. Louis, MO, USA). The purity of the standards was controlled by 
gas chromatography (GC). 
2.3 Quantification of sterols 
Lipid extraction and sterol determination were performed in plasma by a technique which 
processes were shown in tables 1. 
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Plasma levels were quantified by Gas chromatography-mass spectrometry technique 
according to Cold trapping technique, “solvent vent injection” mode. 
Sample pretreatment
Sample dilution: rat plasma sample 50 l in sterile saline 50 l (1:1 dilution). 
Internal standard solution: 5ǂ-cholestane in ethanol 1.26 ± 0.06 mg/ml.                                   
Sterol standard solution: mixed of 
cholesterol/cholestanol/campesterol/stigmasterol/sitosterol in ethanol 2958 ± 0.6/384 ± 
0.2/0.77 ± 231 ± 0.2/60 ± 0.2/302 ± 0.2 g/300 l respectively. 
Saponification and extraction procedure: sample 100 l + “work” internal standard 1 ml 
(internal standard in diethylether/tetrametilammonium hydroxide/isopropanol (1:13:36 
v/v/v) - Incubation at 80°C for 15 min - Extraction by 
tetrachloroethylene/methylbuthyrate 500 l  (1:3 v/v) and sterile water 2 ml. Organic 
phase exsiccation under nitrogen flow and derivatization with Tri-Sil silyling mixture at 
60°C  for an hour. 
Gas chromatography conditions 
Injection volume: extracted solution 2 l.  
Gas chromatograph: GC HP 5890 Agilent with autosampler. 
Gas carrier: highly purified helium. Flow rate: 0.5 ml/min. 
Column conditions: capillary column HP-5MS, 5% PH SM 
Siloxane Crosslinked, heated from 100° C to 280° C for 21 min. 
Detector: mass spectroscope MS 5973 Agilent. 
Oven temperature: 60°C 
Software: HP 5973N, rev D002 for data registration, integration and treatment. 
Assay validation: specificity, detection and quantitation limit, linearity, precision and 
accuracy. Every sample was triple-tested.  
Table 1. Determination of sterols 
2.4 Data analysis 
Results were summarized according to distribution in mean and standard deviation (SD) or 
median and range. Comparisons of means among experiments groups were carried out 
using a 1-tailed analysis of variance test with multiple-comparison tests using the 
Bonferroni option to compare plasma sterol contents among groups. Comparisons of 
medians were performed using the Kruskal Wallis and Wilcoxon test for non parametric 
data. Statistical tests were performed using the STATA Software 11 (Santa Monica, 
California). Then, the results were associated with the liver specimens, which were read by 
two different pathologists, both blinded to the type of nourishment received by the rats and 
unaware of each other’s opinion. Statistical differences were considered significant at a p-
value of <0.05.  
3. Results 
All animals behaved normally during the study. They all gained weights and there was non 
significant differences among groups during the study. Summary of descriptive data is 
summarized in table 2. Serum liver function tests were determined as marker of liver 
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alteration. Total and direct bilirubin, cholesterol, and biliary acid were averagely normal and 
they not differed among groups. Alanine aminotransferase (ALT) and alkaline phosphatase 
(ALKP) reached a statistically difference. Noteworthy, both had a higher level in the control 
group than the others’ receiving TPN. Also glucose (not reached a significant difference), along 
with bile acids were increased in the control group as compared to the other two. Tryglicerides 
(p value= 0.05 borderline) were highly represented in the ILG group. Upon collection, livers 
were noted to be dark red in all groups and their weights were similar.  
 
 IL ILG Control p-value 
Weight delta gr, 
(median/range) 
20 
(5-25)  
15 
(5-20) 
20 
(5-25) 
NS 
ALT U/L 
(median/range) 
39  
(25-69) 
31 
 (13-41) 
56  
(45-201) 
0.018 
ALKP  U/L 
(median/range) 
338  
(69-510)A 
388  
(276-426)B 
578 
(505-657) 
0.016 
Glucose mg/dl 
(median/range) 
264  
(233-312) 
352  
(278-407) 
444 
(303-464) 
NS 
Total bili 
mg/dl 
(median/range) 
0.08 
(0.07-2.55) 
0.03  
(0.03-0.03) 
0.12 
(0.06-0.17) 
NS 
Direct bili 
mg/dl 
(median/range) 
0.02 
(0.02-0-03) 
0.045 
(0.02-0-05) 
0.04 
(0.03-0.04) 
NS 
Bile acids 
micromol/dl 
(median/range) 
12.3  
(9.2-12.6) 
5.7  
(5.2-6.5) 
13.6 
(5.2-56.8) 
NS 
Tryglicerides 
mg/dl 
(median/range) 
98.5  
(79-2691) 
 
303  
(55-428) 
65  
(28-82) 
0.05 
Cholesterol 
mg/dl 
(median/range) 
90  
(29-140) 
85 
(67-136) 
92  
(66-103) 
NS 
ALKP: alkaline phosphatase 
ALT: alanine aminotransferase 
 A:p value= 0.027 compared to control group 
 B: p value= 0.009 compared to control group 
Table 2. Summary of the descriptive data  
The lipids were quantified and classified by type of sterols (animal: cholesterol, and plant: ǃ-
sitosterol, campesterol, and stigmasterol). Table 3 summarizes the total amount of sterols 
given to rats on parenteral nutrition. Table 4 summarizes the amount of lipids extracted 
from plasma and figure  1 shows their plasma concentrations. Animal and plant sterols were 
differently infused in the animals, with the latter generally accounting for a greater share 
than the former. Conversely, the same animal and plant sterols were inversely represented 
with cholesterol content largely predominant in the plasma of rats. Among phytosterols, 
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sitosterol had the highest plasma level in all the groups. Its highest concentrations were 
found in the ILG group, followed by the IL group. Controls had the lowest content, which, 
however, was not significant as differences among groups were not statistically significant. 
Plasma stigmasterol levels were significantly higher in both the IL and ILG groups. This 
time, differences were statistically significant (p=0.000). With respect to stigmasterol, a 
multiple pairwise comparison among groups confirmed a borderline statistically significant 
pairwise differences between IL and the control group (p:0.068). Plasma campesterol levels 
were similar across groups including the one receiving chow and differences were not 
significant.  
 
Rat groups Cholesterol
 
 
 
 
(mg) 
Campesterol
 
 
 
 
(mg) 
 
Stigmasterol
 
 
 
 
(mg) 
 
Sitosterol
 
 
 
 
(mg) 
 
Plant
Sterol
 
 
 
(mg) 
 
Plant 
Sterol 
+ 
Cholesterol 
 
(mg) 
 
IL 3.0 0.68 0.72 2.5 3.9 6.8 
ILG 2.72 0.60 0.64 2.9 3.5 6.2 
Table 3. Overall amount of sterols parenterally injected into the rats 
 
Rat group 
Cholesterol
mean 
 
(μg/ml) 
Colestanol
mean ±SD
 
(μg/ml) 
Campesterol
mean ± SD 
 
(μg/ml) 
Stigmasterol
mean ± SD 
 
(μg/ml) 
Sitosterol 
mean ± SD 
 
(μg/ml) 
Total 
 
 
(μg/ml) 
IL >20.0 0.10 ± 0.1 0.9 ± 0.3 0.11 ± 0.01* 1.80 ± 0.3 22.91 
ILG >20.0 0.12 ± 0.04 0.7 ± 0.2 0.10 ± 0.1 1.50 ± 0.6 22.46 
Chow >20.0 0.20 ± 0.1 0.9 ± 0.2 0.014 ± 0.003 1.30 ± 0.5 22.41 
*:p value= 0.068 when comparing IL with chow 
Table 4. Quantification of plasma level of sterols in rats receiving parenteral, or oral 
nourishment  
After regressing the amounts of provided sterols to the plasma levels identified, a strong 
positive association was found for the stigmasterol (R2=0.83). Weaker associations were 
found for campesterol (R2=0.37) and sitosterol (R2=0.34). 
None of the liver specimens showed abnormalities. Normal hepatic architecture and no 
evidence of PNAC or hepatic steatosis were found in all groups. Minor derangements were 
seen in scattered sections with signs of hepatic hypoxia around the central vein regions, 
which were likely due to the animal’s sacrifice.  
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                                       c               d 
 
 
Fig. 1. Plasma concentrations of sterols 
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4. Discussion 
Scattered reports in the literature have linked PNAC to the vegetable sterol components of 
ILEs (1-5). Information on the sterol contents of ILEs, however, is currently scant and one of 
our previous purpose was to identify animal and plant sterols contained in the most 
representative ILEs. To this end, we selected ILE formulations as being representative in 
terms of their main oil component (soy, olive oil, fish oil variably combined with medium- 
or long-chain fatty acids, and purified triglycerides) and we quantified their animal and 
vegetal sterol contents (6). The relative weight of each sterol, however, varied significantly 
across formulations, but cholesterol and beta-sitosterol were the most represented followed 
by campesterol and stigmasterol. Our second hypothesis was then to verify the distribution 
of these sterols into plasma of rats and check their effects on liver structure. Therefore, in 
this study, we divided inbred weaning rats in three groups (two groups receiving TPN with 
or without glutamine and the third receiving chow) and we determined how sterols were 
distributed in plasma.  Rats’ liver status was also checked to verify whether sterols have 
changed histology in the short term. 
While animal and vegetal sterols were differently represented across ILEs, with the latter 
generally present in greater amounts than the former, the opposite occurred in the plasma of 
rats regardless of their original nourishment. Cholesterol content was largely predominant 
in all groups, followed by sitosterol. Sitosterol was higher in those receiving TPN, although 
its level did not significantly differ among groups and did not correlate with the amount 
supplied. Campesterol  was similarly represented in all three groups, while stigmasterol 
which had the lowest levels, was significantly correlated with the amount supplemented, 
and was even more significantly represented in the IL and ILG groups (p value 0.000). While 
expected in the TPN groups, it was a surprise to have found plant sterols considerably 
present in the plasma of rats fed with chow, given that sterols are usually not absorbed by 
the gastrointestinal system. As in humans, plasma concentrations of plant sterols, all 
detectable at low concentrations, vary at the  individual level due to genetic polymorphism, 
it is possible that similar processes occur in animals. ǃ-sitosterol, which is not endogenously 
produced, is rapidly secreted as neutral sterol into bile more than cholesterol and other 
plant sterols (9). This more rapid fractional turnover of ǃ-sitosterol may indirectly indicate 
that the rigorous exclusion of sterols other than cholesterol in vertebrates may be essential 
for the maintenance of normal cholesterol homeostasis. When mutations affect the 
heterodimers transporter complex, sitosterolemia and hypercholesterolemia occur and 
atherosclerosis may develop. This process was highlighted in homologous animal proteins 
(10,11).  
The association between phytosterols and PNAC has not been confirmed in this study 
carried out over a short term infusion of a high lipid load (40% vs  7 % of fat present in 
chow). These results are in contrast with those from other studies. La Scala et al, for instance, 
showed a direct correlation between the addition of lipids and the development of PNAC, 
which occurred in rats after 3 days of TPN infusion (5). On the contrary, Romestaing et al. 
proved that a long term highly saturated fat diet did not induce steatohepatitis in rats, but 
rather increased peripheral fat storage and thermogenesis (12). Interestingly, laboratory data 
obtained in our study, showed better parameters in the groups receiving ILEs’ as compared 
to those in controls. Even though our original idea was to find an association between TPN 
and liver dysfunction, this finding would go to an opposite direction and be a sign of ILEs’ 
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protection. The ILG group has the lowest GPT level as if the addition of glutamine had 
preserved hepatic functions. As previously reported in the literature, glutamine preserves 
liver glutathione after acute injuries and is able to cleanse the liver of the waste products 
(13). That is why we could have not found any histological alterations in the liver. The 
mechanisms through which phytosterols allegedly activate or, more precisely, influence or 
contribute to a cholestatic process in the liver are obscure. Perhaps the multifactorial origin 
of PNAC does not allow to separately assess the effects of each risk factor. Bypassing the 
gastrointestinal system, a high load of vegetal sterols with ILEs easily overload the blood 
stream and the liver. On top of the infused cholesterol, it is possible that both sterols act 
sinergically or competitively with the liver transporter system, which may displace either 
vegetal or animal sterol excretions and lead to bile duct plugging and initial inflammation. 
With continuous infusion of these sterols, infections, lack of oral intake, multiple drugs use, 
and surgery, the process might worsen. The finding that a patient developed a cirrhosis 
secondary to an autoimmune hepatitis and the combined occurrence of sitosterolemia due to 
a compound heterozygote ABCG8 gene mutation, may reflect a two-hit step and explain the 
need for liver transplantation, which completely reversed the phytosterol storage (14).  
Stigmasterol was the only plant sterol which differentiated the three animal groups. A 
recent study investigating the role of different phytosterols (sitosterol, campesterol, and 
stigmasterol) in the induction of liver damage has shown that stigmasterol is a potent 
antagonist of the nuclear farnesoid X receptor FXR and the ligand-activated pregnane X 
receptor (a member also of the NR superfamily involved in the bile acid metabolism and 
inflammation), while sitosterol and campesterol had minimal or insignificant inhibitory 
effects in a human-derived liver cell line HepG2 (15). In addition to the agonist action of the 
liver X receptors (LXRs) (highly expressed in the liver, adipose tissue, intestine, kidney, and 
macrophages with involvement in sterol transport, fatty acid metabolism, glucose 
regulation, immunity , and cellular response), stigmasterol also interferes with the 
processing of sterol response element binding protein-2 (SREBP-2), which is a central 
regulatory factor in cholesterol metabolism. The nuclear receptor (NR) superfamily has been 
targeted as the main regulator in the adaptive response to cholestasis. In particular, the FXR 
NR1H4 seems to be the key regulator of intrahepatic bile acid levels. To maintain safe levels, 
it reprograms hepatic transcriptional factors reducing sinusoidal bile acid import, 
suppressing bile acid synthesis, and increasing intrahepatic bile acid efflux across 
canalicular and sinusoidal membranes. When FXR NR1H4 is lacking, hepatocytes are more 
susceptible to bile acid-induced injuries in rats. These rats, conversely, do not develop 
cholestasis if FXR NR1H4 is added back (16). Other studies have shown that phytosterols 
inhibit cholesterol 7-ǂ-hydroxylase, which is the rate-limiting step for the conversion of 
cholesterol into bile acids (17). The mechanism by which stigmasterol disrupts cholesterol 
homeostasis activating LXR and suppressing the SREBP pathway was experimentally 
probed in a study in vitro where the authors also identified other sterols such as 
desmosterol, a cholesterol precursor (18). Apparently a double bond in the side chain of the 
sterol structure is responsible for the activation of LXR. Whether ILEs with high content of 
stigmasterol are crucial in the development of PNAC is yet to be proven. However, we 
believe that the solution’s key lays in the interaction between phytosterols and 
phospholipids as proven in a model study in which the effect of the sterols on the molecular 
organization of the phospholipid monolayers was analyzed based on the compression 
modulus values (19). It was found that the incorporation of the phytosterols into the 
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phospholipid monolayers increased their condensation, without affecting the stoichiometry 
of the most stable phospholipids complexes. However, their stability was greatly affected. 
Cholesterol/phospholipids mixtures had the strongest interactions, while systems 
containing stigmasterol had the weakest. 
The use of the intraperitoneal route to infuse TPN could be another explanation for the lack 
of hepatic derangements in this study. The intraperitoneal route is a well established 
procedure to infuse fluids and drugs in rodents (20). We decided to use the intraperitoneal 
route to avoid inserction of an central venous line, which would have exposed animals to 
two of the risk factors involved in the development of hepatic injuries: anesthesia and 
development of central venous line infections.  Both factors would have greatly contributed 
to confuse the final outcome, due to the brief time of observation we planned. The 
intraperitoneal route was effective as the animals did not develop infections and were free 
to move without restrains. 
One final thought goes to the selection of rats used in this study. To reduce the variability 
from selection bias, we decided to use inbred rats. In this way, differences could be totally 
attributed to  the various feeding types as opposed to the inherited patterns of animals.  
In conclusion phytosterols, which predominate in the infused ILEs compared to cholesterol, 
seem to be present in the plasma in quantities lower than cholesterol. No liver histological 
alterations occurred after a short-term high-fat parenteral infusions. These determinations 
will require further confirmation in long-term TPN supplementation and need to be 
analyzed taking into consideration the distribution of animal and plant sterols in the liver 
along with production of oxysterols. 
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